Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

214 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Granulocyte colony-stimulating factor for the induction of T-cell tolerance.
Rutella S. Rutella S. Transplantation. 2007 Jul 15;84(1 Suppl):S26-30. doi: 10.1097/01.tp.0000269611.66517.bf. Transplantation. 2007. PMID: 17632408 Review.
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.
Rutella S, Locatelli F. Rutella S, et al. World J Gastroenterol. 2011 Sep 7;17(33):3761-75. doi: 10.3748/wjg.v17.i33.3761. World J Gastroenterol. 2011. PMID: 21987618 Free PMC article. Review.
DCs in the draining mesenteric lymph nodes, in the intestinal lamina propria and in Peyer's patches partake both in the control of intestinal inflammation and in the maintenance of gut tolerance. ...
DCs in the draining mesenteric lymph nodes, in the intestinal lamina propria and in Peyer's patches partake both in the control of in …
Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.
Rutella S, Filippini P, Bertaina V, Li Pira G, Altomare L, Ceccarelli S, Brescia LP, Lucarelli B, Girolami E, Conflitti G, Cefalo MG, Bertaina A, Corsetti T, Moretta L, Locatelli F. Rutella S, et al. J Transl Med. 2014 Sep 2;12:240. doi: 10.1186/s12967-014-0240-z. J Transl Med. 2014. PMID: 25179788 Free PMC article. Clinical Trial.
Single-dose MZ was given to 30 'poor mobilizers' (PM) failing to attain ≥40 CD34+ HSCs/μL after 4 daily G-CSF doses and/or with predicted apheresis yields ≤12.0x106 CD34+ cells/kg recipient's body weight. ...
Single-dose MZ was given to 30 'poor mobilizers' (PM) failing to attain ≥40 CD34+ HSCs/μL after 4 daily G-CSF doses and/or with predicted ap …
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Bonanno G, Mariotti A, Procoli A, Folgiero V, Natale D, De Rosa L, Majolino I, Novarese L, Rocci A, Gambella M, Ciciarello M, Scambia G, Palumbo A, Locatelli F, De Cristofaro R, Rutella S. Bonanno G, et al. J Transl Med. 2012 Dec 11;10:247. doi: 10.1186/1479-5876-10-247. J Transl Med. 2012. PMID: 23232072 Free PMC article.
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T, Danese S, De Cristofaro R, Rutella S. Di Pucchio T, et al. Expert Opin Ther Pat. 2010 Feb;20(2):229-50. doi: 10.1517/13543770903512974. Expert Opin Ther Pat. 2010. PMID: 20100004 Review.
WHAT THE READER WILL GAIN: Readers will gain an overview of the patented compounds with IDO inhibitory activity from an immunologist's perspective. ...
WHAT THE READER WILL GAIN: Readers will gain an overview of the patented compounds with IDO inhibitory activity from an immunologist's
Function and dysfunction of dendritic cells in autoimmune rheumatic diseases.
Rutella S, De Cristofaro R, Ferraccioli G. Rutella S, et al. Hum Immunol. 2009 May;70(5):360-73. doi: 10.1016/j.humimm.2009.01.023. Hum Immunol. 2009. PMID: 19405176 Review.
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Tarella C, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Moglia C, Ulla M, Omedé P, Bella VL, Corbo M, Silani V, Siciliano G, Mora G, Caponnetto C, Sabatelli M, Chiò A; STEMALS STUDY GROUP. Tarella C, et al. Cytotherapy. 2010;12(1):50-9. doi: 10.3109/14653240903300682. Cytotherapy. 2010. PMID: 19878077 Clinical Trial.
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study).
Leone AM, Galiuto L, Garramone B, Rutella S, Giannico MB, Brugaletta S, Perfetti M, Liuzzo G, Porto I, Burzotta F, Niccoli G, Biasucci LM, Leone G, Rebuzzi AG, Crea F. Leone AM, et al. Am J Cardiol. 2007 Aug 1;100(3):397-403. doi: 10.1016/j.amjcard.2007.03.036. Epub 2007 Jun 8. Am J Cardiol. 2007. PMID: 17659916 Clinical Trial.
214 results
Jump to page
Feedback